Associations of the TyG index, remnant cholesterol levels, and the severity of coronary artery disease: findings from a retrospective study
Frontiers in Cardiovascular Medicine · 19.06.2026 · 13
DOI: 10.3389/fcvm.2026.1786243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 19.06.2026. Verfasst von Xi Meng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aimed to investigate whether the triglyceride-glucose (TyG) index mediates the association between remnant cholesterol (RC) and coronary artery disease (CAD) severity and to evaluate their combined association with multi-vessel CAD.
Methods
In this retrospective study, anonymized data from CAD patients undergoing coronary computed tomography angiography (CCTA) or coronary angiography (CAG) between 2019 and 2022 were analyzed . Patients were classified into single-vessel or multi-vessel disease groups. Insulin resistance was estimated using the TyG index, and RC was calculated. Multivariate logistic regression, restricted cubic spline (RCS) modeling, and mediation analysis were utilized to explore the relationships among the TyG index, RC, and CAD severity.
Results
A total of 592 patients (64.7% male; mean age, 62 years) were included in the analysis. The TyG index was positively correlated with RC ( r = 0.52, P < 0.001). After adjustment for confounding factors, each 1-SD increase in the TyG index was associated with higher odds of multi-vessel CAD (OR = 1.724; 95% CI, 1.323–2.247; P < 0.001), and each 1-SD increase in the RC was similarly associated with higher odds of multi-vessel CAD (OR = 1.491; 95% CI, 1.024–2.171; P = 0.037). Patients with both high TyG index and high RC had significantly higher odds of multi-vessel CAD (OR = 3.53; 95% CI, 2.040–6.258; P < 0.001). Mediation analysis demonstrated that the TyG index mediated 33% of the association between RC and multi-vessel CAD.
Conclusions
The TyG index is positively correlated with RC and is significantly associated with CAD severity. Furthermore, the TyG index partially mediates the association between RC and CAD severity. Combined assessment of the TyG index and RC may improve metabolic risk stratification in patients with CAD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.
- NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
- Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zitieren
APA
Meng, X., Duanmu, Y., Yu, X., Liu, L., Cui, Y., Chen, Z., Ji, G., Zhang, D., Yang, X., Liu, X., & Wu, W. (2026). Associations of the TyG index, remnant cholesterol levels, and the severity of coronary artery disease: findings from a retrospective study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1786243
Vancouver
Meng X, Duanmu Y, Yu X, Liu L, Cui Y, Chen Z, et al. Associations of the TyG index, remnant cholesterol levels, and the severity of coronary artery disease: findings from a retrospective study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1786243
BibTeX
@article{Meng2026,
author = {Meng, Xi and Duanmu, Yibo and Yu, Xiaoyi and Liu, Lijie and Cui, Yuhui and Chen, Zhimin and Ji, Guiyuan and Zhang, Dantao and Yang, Xingfen and Liu, Xilong and Wu, Wei},
title = {Associations of the TyG index, remnant cholesterol levels, and the severity of coronary artery disease: findings from a retrospective study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1786243}
}
EUVIMED